Login / Signup
Targeting interleukin-5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms.
Emanual Maverakis
Antonio Ji-Xu
Marie-Charlotte Brüggen
Published in:
Allergy (2022)
Keyphrases
</>
cancer therapy
emergency department
drug induced
drug delivery
adverse drug